Clinical Study
Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer
Table 4
Univariate and multivariate Cox regression analysis for the prognostic factors of overall survival.
| | Univariate | Multivariate | | value | HR (95% CI) | value | HR (95% CI) |
| Age (years) ≥65 | 0.269 | | | | Male | 0.761 | | | | Oropharynx | 0.014 | 0.391 (0.185–0.829) | 0.000 | 0.261 (0.116–0.586) | Extracapsular spread | 0.012 | 2.443 (1.219–4.895) | 0.007 | 2.709 (1.312–5.592) | Pathologic staging | | | | | pT > 2 | 0.894 | | | | pN > 1 | 0.472 | | | | p16INK4A | 0.583 | | | | Regional lymph node involvement | 0.501 | | | | Resection margin status | 0.891 | | | | Tumor emboli | 0.476 | | | | Perineural invasion | 0.611 | | | | Lymphovascular invasion | 0.892 | | | | Total radiation dose ≥60 Gy | 0.012 | 0.285 (0.107–0.761) | 0.007 | 0.241 (0.086–0.679) | Weekly chemotherapy ≥7 cycle | 0.152 | | | |
|
|
HR: hazard ratio; CI: confidence interval.
|